Quarterly report
Open the filing on sec.gov
NuSkin Enterprises, Inc. (NUS)
NYSE: NUS · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Provo, UT · filing with the SEC since 1996
Grade6.1
◀ Past 6.2● Present 6.3▶ Future 5.6
The companyfiscal 2025, as filed
Revenue$1.49B-14.3%
Net income$160M+209.3%
Earnings per share$3.18+207.8%
Operating cash flow$80.3M-28.2%
Cash$239M+27.7%
Debt$204M-43.8%
Shareholders’ equity$805M+23.6%
Shares, diluted50.3M+1.3%
Return on equity19.9%
The recordfrom its filings
Filings in 202657
Newest filingNov 6 · 10-Q
Annual reportFeb 13, 2026
Quarterly reportNov 6, 2026
Next report due10-K by Mar 16
Insider sales, 12 months$100,000
Insider buys, 12 months$100,000
Patents granted104
Filer categoryAccelerated filer
Trailing twelve months to Sep 2026Revenue $1.32BNet income -$234MCash from operations $15.2Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Results released
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.